R

Redbiotec AG

11 employees

Pioneer in therapeutic bacteria for treating cancer and genetic disorders

Basic info

Industry

biotechnology research

Sectors

Oncolytic bacteria
Biotechnology
Protein engineering
Gene therapy delivery
Herpes
Pharmaceutical
Vaccines
Oncolytic virus
HSV-2
Immuno-oncology
Virus-like particles (VLPs)
Protein complexes
HPV
Proteins
Therapeutic vaccine
Immunotherapy
Biologics
Pancreatic cancer
Therapeutics
Microbial engineering
Cervical cancer

Date founded

2006

Funding rounds raised

R

Redbiotec AG raised undisclosed on November 27, 2014

Investors: Redalpine

FAQ